A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone.

The study appears in Nature Communications.

"For a number of breast cancer patients, the problem is metastasis -- the dissemination of breast tumour cells to other organs -- after the primary tumour has been eliminated," said corresponding author Dr Xiang Zhang, associate professor of molecular and cellular biology and the Lester and Sue Smith Breast Center at Baylor. "Metastases, however, tend to respond differently than the primary tumour to the treatment in part due to residing in a different organ with a different microenvironment."

Until now, there has not been an effective experimental platform to study metastatic tumours in their new microenvironment.

"We have created an experimental system in which we can mimic the interactions between cancer cells and bone cells, as bone is the place where breast cancer, and many other cancers too, disseminates most frequently," said Zhang, who also is a McNair Scholar at Baylor. "We have developed a system that allows us to test many different drug responses simultaneously to discover the therapy that can selectively act on metastatic cancer cells and minimise the effect on the bone."

To mimic the interactions between metastatic breast cancer cells and bone cells in a living system in the lab, Zhang and his colleagues developed a bone metastasis model, called bone-in culture array, by fragmenting mouse bones that already contain breast cancer cells.

Zhang and his colleagues developed a bone metastasis model, called bone-in culture array, by fragmenting mouse bones that already contain breast cancer cells.

The scientists determined that the bone-in culture maintains the microenvironmental characteristics of bone metastasis in living animal models, and the cancer cells maintain the gene expression profile, the growth pattern and their response to therapies.

Using the bone-in model, the researchers determined that the drug danusertib preferentially inhibits bone metastasis.

They also found that other drugs stimulate the growth of slow-growing cancer cells in the bone.

In addition to determining the effect of drugs in the growth of metastasis in bone, the bone-in culture can be used to investigate mechanisms involved in bone colonisation by cancer cells.

"We think that this new system has the potential to be applied not only to breast cancer but to other cancers that also metastasise to the bone," Zhang said. "This technique can be scaled up to larger sample sizes, which would help accelerate the process of discovering metastatic cancer treatments. We have already found a few interesting drugs. We will keep looking for more and focus on those that are most promising."

In the future, the scientists expect to develop this platform into a standardised system that can be used in the clinic to find specific drugs that can better treat metastatic cancer.

Source: Baylor College of Medicine